Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | DHFR | P00374 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL27617988 | 0.98 | MEN1 (0.47) | MEN1ALDH1A1GAAMAPTMAPK1 | |
| SCHEMBL33992 | 0.86 | — | — | |
| SCHEMBL27887980 | 0.86 | HRH4 (0.41) | DHFR | |
| Water SCHEMBL27925192 | 0.84 | HRH4 (0.39) | DHFR | |
| Hydrochloric Acid SCHEMBL27615453 | 0.84 | HRH4 (0.39) | DHFR | |
| Sulfurous Acid SCHEMBL7593670 | 0.83 | DHFR (0.37) | MEN1ALDH1A1GAAMAPTMAPK1 | |
| SCHEMBL27776478 | 0.78 | DHFR (0.37) | DHFR | |
| Alcohol SCHEMBL27990339 | 0.78 | DHFR (0.44) | DHFR | |
| SCHEMBL23718251 | 0.77 | KDM4E (0.38) | MEN1ALDH1A1GAAMAPTMAPK1 | |
| SCHEMBL21141871 | 0.75 | DHFR (0.35) | DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118812535-A | Novel folic acid synthesis method | 天津大学 | 2024-10-22 | — | — | CN | claimed |
| CN-118724905-A | Recovery and reuse method of folic acid wastewater | 天津大学 | 2024-10-01 | — | — | CN | claimed |
| CN-116550263-A | Folic acid preparation device and preparation method thereof | 安徽新鸿药业有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-113521052-A | Multivitamin iron capsule and preparation method thereof | 海南金贝康制药有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-107365311-B | Preparation method and application of trans-folic acid | 浙江圣达生物药业股份有限公司 | 2020-04-21 | — | — | CN | claimed |
| CN-107365311-A | A kind of preparation method and applications of trans folic acid | 浙江圣达生物药业股份有限公司 | 2017-11-21 | — | — | CN | claimed |
| CN-107353299-A | A kind of preparation method and applications of pteridine folic acid | 浙江圣达生物药业股份有限公司 | 2017-11-17 | — | — | CN | claimed |
| WO-2014141288-A1 | THE ART, METHOD, MANNER, PROCESS AND SYSTEM OF A NANO-BIOMINERAL FOR MULTI-MODAL CONTRAST IMAGING AND DRUG DELIVERY | AMRITA VISHWA VIDYAPEETHAM UNIVERSITY (IN) | 2014-09-18 | — | — | WO | claimed |
| CN-102812348-A | SERS-based Analyte Detection | AGENCY SCIENCE TECH & RES | 2012-12-05 | — | — | CN | claimed |
| CN-118812535-A | Novel folic acid synthesis method | 天津大学 | 2024-10-22 | — | — | CN | disclosed |
| CN-118812535-A | Novel folic acid synthesis method | 天津大学 | 2024-10-22 | — | — | CN | disclosed |
| CN-118724905-A | Recovery and reuse method of folic acid wastewater | 天津大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-118724905-A | Recovery and reuse method of folic acid wastewater | 天津大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-116550263-A | Folic acid preparation device and preparation method thereof | 安徽新鸿药业有限公司 | 2023-08-08 | — | — | CN | disclosed |
| EP-1440072-A4 | PURINE ANALOGS HAVING HSP90-INHIBITING ACTIVITY | CONFORMA THERAPEUTIC CORP (US) | 2005-02-02 | — | — | EP | disclosed |
| US-20040167198-A1 | Vasculostatic agents and methods of use thereof | TARGEGEN, INC. | 2004-08-26 | — | — | US | disclosed |
| EP-1440072-A2 | PURINE ANALOGS HAVING HSP90-INHIBITING ACTIVITY | Conforma Therapeutic Corporation (US) | 2004-07-28 | — | — | EP | disclosed |
| WO-2004030635-A2 | VASCULOSTATIC AGENTS AND METHODS OF USE THEREOF | TARGEGEN, INC. (US) | 2004-04-15 | — | — | WO | disclosed |
| WO-2003037860-A2 | PURINE ANALOGS HAVING HSP90-INHIBITING ACTIVITY | CONFORMA THERAPEUTICS CORPORATION (US) | 2003-05-08 | — | — | WO | disclosed |
| EP-1202374-A1 | LITHIUM SECONDARY CELL | NGK INSULATORS, LTD. (JP) | 2002-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167198-A1 | Vasculostatic agents and methods of use thereof | RBP1, RBP4, VCAM1 | MEN1 1480/4885ALDH1A1 745/4885GAA 3609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.